Lawrenceville, NJ, United States of America

Brian Carlin

USPTO Granted Patents = 2 


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Brian Carlin: Innovator in Pharmaceutical Formulations

Introduction

Brian Carlin is a notable inventor based in Lawrenceville, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of excipients for tablet formulations. With a total of 2 patents to his name, Carlin's work has advanced the efficiency and effectiveness of solid dosage forms.

Latest Patents

Carlin's latest patents include innovative methods and compositions that enhance tablet formulations. One of his patents focuses on a co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations. This composition, which includes mannitol as a preferred sugar alcohol, demonstrates improved compactability, lubricant sensitivity, and ejection profile compared to traditional formulations. Another patent details a method for preparing microcrystalline cellulose-containing tablets through roller compaction, which allows for the creation of dry granulates that can be efficiently compacted into tablets.

Career Highlights

Brian Carlin is currently employed at FMC Corporation, where he continues to push the boundaries of pharmaceutical innovation. His work has not only contributed to the development of new formulations but has also set standards for evaluating binders in tablet production.

Collaborations

Throughout his career, Carlin has collaborated with esteemed colleagues such as Gregory Thoorens and Bruno LeClercq. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Brian Carlin's contributions to the field of pharmaceutical formulations exemplify the impact of innovative thinking in the industry. His patents and ongoing work at FMC Corporation highlight the importance of advancements in excipients and tablet formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…